Infectious Diseases News and Research

RSS

Intravenous catheter replacement should take place only when clinically necessary

New research published in the third Article in The Lancet surgery-themed issue suggests that the millions of intravenous catheters used each year can be safely changed only when clinically necessary, overturning 40 years of accepted practice involving routine replacement every 3 days.

21 Sep 2012

Strand Life Sciences to validate and commercialize Trovagene's urine-based HPV test

Trovagene, Inc. and Strand Life Sciences Pvt Ltd., of Bangalore, India, completed their agreement to validate and commercialize Trovagene's proprietary urine-based Human Papillomavirus (HPV) test for clinical diagnostic and carrier screening use.

21 Sep 2012

Mosquitoes show signs of behavior change in response to bed net use, study says

About three years after two villages in Benin began using insecticide-treated bed nets to help prevent malaria, mosquitoes in the area changed their biting habits, so their "hours of 'peak aggression' [went] from 2 a.m. or 3 a.m. to around 5 a.m." and "in one village, the proportion of mosquito bites inflicted outdoors rose," according to a study published in the Journal of Infectious Diseases, Reuters reports.

21 Sep 2012

Medivir’s simeprevir and TMC647055 to enter phase IIa combination trial for HCV genotype-1

Medivir AB, announced today that simeprevir (TMC435) and TMC647055, a non-nucleoside inhibitor (NNI) will enter a phase IIa interferon free combination trial.

21 Sep 2012

TB Alliance, Sanofi partner to discover and develop novel compounds against tuberculosis

Sanofi and the Global Alliance for TB Drug Development announced today a new research collaboration agreement to accelerate the discovery and development of novel compounds against tuberculosis (TB), a deadly infectious disease that resulted in almost 1.5 million deaths worldwide in 2010.

21 Sep 2012

Tight glycemic control does not reduce infection rate after pediatric cardiac surgery

Implementing tight glycemic control after surgery with cardiopulmonary bypass does not reduce the rate of healthcare-associated infections among pediatric patients, compared with standard care in the intensive care unit, show US study results.

20 Sep 2012

Scientists identify unique molecular signature in iPSCs that show promise in regenerative medicine

Salk scientists have identified a unique molecular signature in induced pluripotent stem cells (iPSCs), "reprogrammed" cells that show great promise in regenerative medicine thanks to their ability to generate a range of body tissues.

20 Sep 2012

Study uncovers why some HIV-positive people take long time to progress to full-blown AIDS

One of the big mysteries of AIDS is why some HIV-positive people take more than a decade to progress to full-blown AIDS, if they progress at all.

20 Sep 2012

BGI Tech achieves whole exome sequencing analysis of total degraded DNA from FFPE samples

BGI Tech Solutions Co., Ltd., a subsidiary company of BGI, announced today that they have achieved whole exome sequencing analysis of total degraded DNA as low as 200 ng from formalin fixed paraffin embedded (FFPE) samples.

19 Sep 2012

Xenex's pulsed xenon UV more effective than bleach in decontaminating C. diff surfaces

Healthcare associated infections (also referred to as HAIs or hospital acquired infections) are the fourth leading cause of death in the United States, costing more than $30 billion each year. Evidence continues to mount that hospital cleanliness plays a role in the spread of HAIs, which are caused by deadly pathogens such as C. diff, MRSA, VRE and Acinetobacter.

19 Sep 2012

Vitamin D deficiency common in critically ill children

Children who are critically ill frequently have low serum levels of vitamin D, report researchers.

18 Sep 2012

Tranexamic acid lifesaving across the board

Tranexamic acid confers survival benefits in trauma patients irrespective of their baseline mortality risk, shows a prespecified analysis of CRASH-2.

18 Sep 2012

Harris Health System celebrates completion of Smith Clinic

On Sept. 12, Harris Health System celebrated the completion of Smith Clinic, the system's first outpatient specialty facility. The new facility enhances and expands specialty care for patients formerly seen at hospital-based clinics located at Ben Taub Hospital.

18 Sep 2012

No association between XMRV/pMLV and chronic fatigue syndrome

The causes of chronic fatigue syndrome (CFS) have long eluded scientists. In 2009, a paper in the journal Science linked the syndrome-sometimes called myalgic encephalomyelitis (ME)-to infection with a mouse retrovirus called XMRV (xenotropic murine leukemia virus (MLV)-related virus).

18 Sep 2012

Pacific Global Health Conference to take place from Oct. 8-10

Over 400 leading health professionals are expected to attend the 5th Pacific Global Health Conference, Transforming Public Health in the Pacific, to be held at the Ala Moana Hotel in Honolulu, HI from October 8-10.

18 Sep 2012

FDA clears Meridian Bioscience’s new illumigene Group A Strep test

Meridian Bioscience, Inc., Cincinnati, Ohio today announced that it has received FDA clearance for a new molecular diagnostic test for Group A Streptococcus on the illumigene platform.

18 Sep 2012

Novel classification system could improve management of facial trauma

A novel scoring system based on the “best” elements of four existing systems can successfully differentiate injuries of patients with complex facial fractures, improving discrimination between severe injuries, report UK researchers.

17 Sep 2012

New test to assess viral load of cytomegalovirus

Roche announced today the commercial availability of a new test to assess a patient's viral load of cytomegalovirus (CMV). Physicians use information from the test to help them manage patients who have been diagnosed with CMV disease, specifically patients with an immune system that has been suppressed for solid organ transplantation.

From Roche Sequencing and Life Science 17 Sep 2012

FDA designates Rib-X's delafloxacin as QIDP for acute bacterial skin and skin structure infections

Rib-X Pharmaceuticals, Inc., today announced that the Food and Drug Administration (FDA) designated delafloxacin as a Qualified Infectious Disease Product (QIDP) for the indications of acute bacterial skin and skin structure infections (ABSSSI) and community-acquired bacterial pneumonia (CABP).

17 Sep 2012

Natural antibiotic to treat tuberculosis

A natural product secreted by a soil bacterium shows promise as a new drug to treat tuberculosis report scientists in a new study published in EMBO Molecular Medicine. A team of scientists working in Switzerland has shown how pyridomycin, a natural antibiotic produced by the bacterium Dactylosporangium fulvum, works.

17 Sep 2012

Infectious Diseases News and Research

Intravenous catheter replacement should take place only when clinically necessary

Strand Life Sciences to validate and commercialize Trovagene's urine-based HPV test

Mosquitoes show signs of behavior change in response to bed net use, study says

Medivir’s simeprevir and TMC647055 to enter phase IIa combination trial for HCV genotype-1

TB Alliance, Sanofi partner to discover and develop novel compounds against tuberculosis

Tight glycemic control does not reduce infection rate after pediatric cardiac surgery

Scientists identify unique molecular signature in iPSCs that show promise in regenerative medicine

Study uncovers why some HIV-positive people take long time to progress to full-blown AIDS

BGI Tech achieves whole exome sequencing analysis of total degraded DNA from FFPE samples

Xenex's pulsed xenon UV more effective than bleach in decontaminating C. diff surfaces

Vitamin D deficiency common in critically ill children

Tranexamic acid lifesaving across the board

Harris Health System celebrates completion of Smith Clinic

No association between XMRV/pMLV and chronic fatigue syndrome

Pacific Global Health Conference to take place from Oct. 8-10

FDA clears Meridian Bioscience’s new illumigene Group A Strep test

Novel classification system could improve management of facial trauma

New test to assess viral load of cytomegalovirus

FDA designates Rib-X's delafloxacin as QIDP for acute bacterial skin and skin structure infections

Natural antibiotic to treat tuberculosis

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News